DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
28 hedge funds and large institutions have $249K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less capital invested
Capital invested by funds: $758K → $249K (-$509K)
Holders
28
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$36.1K | |
| 2 | +$867 | |
| 3 | +$641 | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$424 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$135 |
Top Sellers
| 1 | -$20.4K | |
| 2 | -$9.32K | |
| 3 | -$4.38K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$94 |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
-$85 |